β2M has been reported as a growth-, angiogenesis-, EMT-, and bone metastasis-stimulating factor in various solid tumor malignancies [9], but inconsistent effects on breast cancer have been reported [14, 16–20]. Here, B2M is linked to breast carcinoma.